The Technical Analyst
111 Inc [YI]
Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
111 Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.67% $1.050
America/New_York / 24 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 87.69 mill |
| EPS: | -0.490 |
| P/E: | -2.14 |
| Earnings Date: | Jun 13, 2024 |
| SharesOutstanding: | 83.52 mill |
| Avg Daily Volume: | 0.0671 mill |
| RATING 2024-04-24 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.14 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.29x |
| Company: PE -2.14 | industry: PE 7.30 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.941 - 1.159 ( +/- 10.38%) |
| ATR Model: 14 days |
Forecast:
16:00 - $1.050
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.050
Forecast 2: 16:00 - $1.050
Forecast 3: 16:00 - $1.050
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.050 (-3.67% ) |
| Volume | 0.0117 mill |
| Avg. Vol. | 0.0671 mill |
| % of Avg. Vol | 17.35 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For YI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
YI
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Last 10 Buy Signals
Latest Press Releases
2024-03-21 04:47:00 - Press Release
111, Inc. Announces Fourth Quarter And Fiscal Year 2023 Financial Results
Shanghai , march 21, 2024 /prnewswire/ -- 111, inc. ("111" or the "company") (nasdaq: yi), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in china, today announced its unaudited financial results for the fourth quarter and fiscal year ended december 31, 2023. fourth quarter 2023 highlights net revenues were rmb4.1 billion (us$578.7 million), representing a decrease of 1.0% year-over-year.
2024-03-01 04:00:00 - Press Release
111 To Announce Fourth Quarter And Fiscal Year 2023 Unaudited Financial Results- Conference Call To Follow
Shanghai , march 1, 2024 /prnewswire/ -- 111, inc. (nasdaq: yi) ("111" or the "company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in china, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2023 ended december 31, 2023, before the u.s. market opens on thursday, march 21, 2024. 111's management team will host an earnings conference call at 7:30 am u.s. eastern time on thursday, march 21, 2024 (7:30 pm beijing time on the same day).
2024-02-27 08:58:00 - Press Release
111 Announces Receipt Of Withdrawal Of Going Private Proposal
Shanghai , feb. 27, 2024 /prnewswire/ -- 111, inc. ("111" or the "company") (nasdaq: yi), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in china, today announced that it has received a notice dated feburary 27, 2024 on behalf of the consortium comprising dr. gang yu, co-founder and co-chairman of the company, mr. junling liu, co-founder, co-chairman and chief executive officer of the company and certain other investors (collectively, the "consortium"), stating that the consortium would withdraw its preliminary non-binding going private proposal dated september 9, 2022 and preliminary non-binding going private proposal dated october 29, 2022 (collectively, the "proposals").
2023-11-30 01:00:00 - Press Release
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
Shanghai , nov. 30, 2023 /prnewswire/ -- 111, inc. ("111" or the "company") (nasdaq: yi), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in china, today announced its unaudited financial results for the third quarter ended september 30, 2023. third quarter 2023 highlights net revenues were rmb3.7 billion (us$502.4 million), representing an increase of 9.5% year-over-year.
2023-11-13 00:10:00 - Press Release
111 To Announce Third Quarter 2023 Unaudited Financial Results On November 30, 2023 - Conference Call To Follow
Shanghai , nov. 13, 2023 /prnewswire/ -- 111, inc. (nasdaq: yi) ("111" or the "company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in china, today announced that it will report its unaudited financial results for the third quarter ended september 30, 2023, before the u.s. market opens on thursday, november 30, 2023. 111's management team will host an earnings conference call at 7:30 am u.s. eastern time on thursday, november 30, 2023 (8:30 pm beijing time on the same day).
Latest News
2024-03-21 15:23:03 - Seeking Alpha
111, Inc. (YI) Q4 2023 Earnings Call Transcript
2024-03-01 04:00:00 - PRNewsWire
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2023 ended December 31, 2023, before the U.S. market opens on Thursday, March 21, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 21, 2024 (7:30 PM Beijing Time on the same day).
2023-11-23 05:52:59 - InvestorPlace
3 Top M&A Plays: Lucrative Merger Deals Poised for Big Payoffs
In the US business landscape, strategic mergers and acquisitions often set the stage for remarkable returns for shareholders. In the wake of economic shifts, three key M&A plays emerge as focal points, poised to redefine market dynamics and investor strategies.
2023-11-13 00:10:00 - PRNewsWire
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow
SHANGHAI , Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2023, before the U.S. market opens on Thursday, November 30, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 30, 2023 (8:30 PM Beijing Time on the same day).
2023-05-25 02:05:00 - PRNewsWire
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens on Thursday, June 15, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 15, 2023 (7:30 PM Beijing Time on the same day).
2023-03-24 01:15:04 - Seeking Alpha
111, Inc. (YI) Q4 2022 Earnings Call Transcript
111, Inc. (NASDAQ:YI ) Q4 2022 Earnings Conference Call March 23, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Harvey Wang - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Stephen Lee - Individual Investor Tom Craig - Cornerstone Investment Francis Yang - BSV Capital Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
2023-03-02 02:35:00 - PRNewsWire
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow
SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2022 ended December 31, 2022, before the U.S. market opens on Thursday, March 23, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 23, 2023 (7:30 PM Beijing Time on the same day).
2022-12-15 06:23:16 - Seeking Alpha
111, Inc.: Privatization With An Interesting Twist
111, Inc. has received a non-binding proposal to be acquired by a consortium led by the company's founders at $3.66/ADS. YI share price has recently soared, jumping to as much as 9% above the offer and seems to have settled slightly below the privatization price.
2022-12-01 13:19:05 - Seeking Alpha
111, Inc. (YI) Q3 2022 Earnings Call Transcript
111, Inc. (NASDAQ:YI ) Q3 2022 Earnings Conference Call December 1, 2022 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer, Major Subsidiary Harvey Wang - Chief Operating Officer Monica Mu - Investor Relations Director Conference Call Participants Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
2022-11-08 01:09:00 - PRNewsWire
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow
SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, before the U.S. market opens on Thursday, December 1, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, December 1, 2022 (8:30 PM Beijing Time on the same day).